PAMJ Clinical Medicine (Jul 2020)

Rivaroxaban induced retro peritoneal hematoma: a rare complication of direct oral anticoagulants (DOACs)

  • Bouaiyda Ayoub,
  • Chouikh Chakib,
  • Grine Ali,
  • Jeddab Achraf,
  • Mounir Khalil,
  • Balkhi Hicham

DOI
https://doi.org/10.11604/pamj-cm.2020.3.124.24674
Journal volume & issue
Vol. 3, no. 124

Abstract

Read online

Direct oral anticoagulants have revolutionized the management of patients requiring long-term anticoagulation, as they are easy to handle, do not require biological monitoring, the dosage is standardized and hemorrhagic events are rare. Hemorrhagic events under this type of anticoagulation are rare and may involve several locations. We are going to present the case of a patient followed for non-valvular atrial fibrillation on rivaroxaban who presented to the emergency department with intense left lumbar pain with hemodynamic instability, and whose investigations came back in favor of a retroperitoneal hematoma, this type of hemorrhagic event related to rivaroxaban, to our knowledge and the first in the literature, we are going to present the case of this patient by detailing the management and the difficulties envisaged during her management.

Keywords